银座股份: 银座股份2025年第三次临时股东大会资料

Core Viewpoint - The company plans to distribute cash dividends to shareholders based on its financial performance for the first half of 2025, while also proposing structural changes to its governance by abolishing the supervisory board and amending its articles of association [1][2]. Financial Performance and Dividend Distribution - As of June 30, 2025, the company's undistributed profits amounted to 16,864,833.16 yuan, with a proposed cash dividend of 0.15 yuan per 10 shares, totaling approximately 7,800,998.84 yuan [1]. - The total share capital as of the same date was 520,066,589 shares, and the proposed cash dividend represents 7.49% of the company's net profit [1]. Governance Changes - The company intends to abolish the supervisory board to enhance its governance structure, transferring the supervisory responsibilities to the audit committee of the board of directors [2]. - Amendments to the articles of association will include expanding the business scope to include retail of pharmaceuticals and internet services related to medical devices [2][3]. Articles of Association Amendments - The revisions to the articles of association will reflect changes in governance and operational scope, ensuring compliance with relevant laws and regulations [3][4]. - Specific amendments include the addition of new business activities and the restructuring of the roles and responsibilities of the board and management [4][5].